Balance Sheet
Daily Values
Growth Metrics
Income Statement
Shares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Ascendis Pharma A (ASND) Shares Outstanding (Diluted Average) (2016 - 2023)

Ascendis Pharma A's Shares Outstanding (Diluted Average) history spans 8 years, with the latest figure at $7.0 million for Q4 2023.

  • For Q4 2023, Shares Outstanding (Diluted Average) changed 0.23% year-over-year to $7.0 million; the TTM value through Dec 2023 reached $7.0 million, changed 0.23%, while the annual FY2023 figure was $7.1 million, 2.45% down from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2023 was $7.0 million at Ascendis Pharma A, roughly flat from $7.0 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $8.1 million in Q4 2021 and bottomed at $6.4 million in Q4 2019.
  • The 5-year median for Shares Outstanding (Diluted Average) is $7.0 million (2023), against an average of $7.2 million.
  • The largest annual shift saw Shares Outstanding (Diluted Average) grew 13.78% in 2020 before it dropped 13.6% in 2022.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $6.4 million in 2019, then rose by 13.78% to $7.3 million in 2020, then grew by 10.57% to $8.1 million in 2021, then fell by 13.6% to $7.0 million in 2022, then rose by 0.23% to $7.0 million in 2023.
  • Per Business Quant, the three most recent readings for ASND's Shares Outstanding (Diluted Average) are $7.0 million (Q4 2023), $7.0 million (Q4 2022), and $8.1 million (Q4 2021).